BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21887732)

  • 21. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus in the management of hospitalized patients with steroid-refractory ulcerative colitis: don't forget cytomegalovirus!
    Roblin X; Del Tedesco E
    Inflamm Bowel Dis; 2013 Apr; 19(5):E67-8. PubMed ID: 23314247
    [No Abstract]   [Full Text] [Related]  

  • 23. Response of refractory colitis to intravenous or oral tacrolimus (FK506).
    Fellermann K; Tanko Z; Herrlinger KR; Witthoeft T; Homann N; Bruening A; Ludwig D; Stange EF
    Inflamm Bowel Dis; 2002 Sep; 8(5):317-24. PubMed ID: 12479646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
    Tamaki H; Nakase H; Inoue S; Kawanami C; Itani T; Ohana M; Kusaka T; Uose S; Hisatsune H; Tojo M; Noda T; Arasawa S; Izuta M; Kubo A; Ogawa C; Matsunaka T; Shibatouge M
    Dig Endosc; 2016 Jan; 28(1):67-74. PubMed ID: 26418574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
    Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
    J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
    Lazzerini M; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Lorusso M; Mangiantini F; Fontana M; Zuin G; Palla G; Maggiore G; Bramuzzo M; Pellegrin MC; Maschio M; Villanacci V; Manenti S; Decorti G; De Iudicibus S; Paparazzo R; Montico M; Ventura A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1739-49. PubMed ID: 26185909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis.
    Watson S; Pensabene L; Mitchell P; Bousvaros A
    Inflamm Bowel Dis; 2011 Jan; 17(1):22-9. PubMed ID: 20722055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.
    Boschetti G; Nancey S; Moussata D; Stefanescu C; Roblin X; Chauvenet M; Stroeymeyt K; Bouhnik Y; Flourié B
    Dig Liver Dis; 2014 Oct; 46(10):875-80. PubMed ID: 25023007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis.
    Högenauer C; Wenzl HH; Hinterleitner TA; Petritsch W
    Aliment Pharmacol Ther; 2003 Aug; 18(4):415-23. PubMed ID: 12940927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.
    Navas-López VM; Blasco Alonso J; Serrano Nieto MJ; Girón Fernández-Crehuet F; Argos Rodriguez MD; Sierra Salinas C
    J Crohns Colitis; 2014 Jan; 8(1):64-9. PubMed ID: 23582736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
    Ashizuka S; Inatsu H; Kita T; Kitamura K
    Dig Dis Sci; 2016 Mar; 61(3):872-80. PubMed ID: 26470867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
    Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
    Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
    Sandborn WJ; Hanauer S; Lichtenstein GR; Safdi M; Edeline M; Scott Harris M
    Aliment Pharmacol Ther; 2011 Oct; 34(7):747-56. PubMed ID: 21848857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
    Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
    J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis.
    Yoshimura N; Watanabe M; Motoya S; Tominaga K; Matsuoka K; Iwakiri R; Watanabe K; Hibi T;
    Gastroenterology; 2015 Dec; 149(7):1775-1783.e2. PubMed ID: 26327130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus as rescue therapy for steroid-dependent/steroid-refractory ulcerative colitis: Experience from tertiary referral center in India.
    Sud S; Sachdeva S; Puri AS
    Indian J Gastroenterol; 2021 Dec; 40(6):598-603. PubMed ID: 34971402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
    Wu B; Tong J; Ran Z
    Inflamm Bowel Dis; 2020 Jan; 26(1):24-32. PubMed ID: 30980713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis.
    Leiper K; Martin K; Ellis A; Subramanian S; Watson AJ; Christmas SE; Howarth D; Campbell F; Rhodes JM
    Gut; 2011 Nov; 60(11):1520-6. PubMed ID: 21471566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.